Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 2,973 | 2,747 | 2,749 | 2,752 | 3,236 |
| Gross Profit | 2,973 | 2,747 | 2,749 | 2,752 | 3,236 |
| Operating Expenses | 3,121 | 3,331 | 3,772 | 4,180 | 3,715 |
| Operating Income | -148 | -584 | -1,023 | -1,428 | -479 |
| Other Income | 178 | 193 | 208 | 228 | 272 |
| Pre-tax Income | 30 | -391 | -815 | -1,200 | -207 |
| Net Income Continuous | 30 | -391 | -815 | -1,200 | -207 |
| Net Income | $30 | $-391 | $-815 | $-1,200 | $-207 |
| EPS Basic Total Ops | 0.00 | -0.04 | -0.14 | -0.21 | -0.03 |
| EPS Basic Continuous Ops | 0.00 | -0.06 | -0.13 | -0.19 | -0.03 |
| EPS Diluted Total Ops | 0.00 | -0.04 | -0.14 | -0.21 | -0.03 |
| EPS Diluted Continuous Ops | 0.00 | -0.06 | -0.13 | -0.19 | -0.03 |
| EBITDA(a) | $-113 | $-549 | $-988 | $-1,388 | $-426 |